Skip to main content

When Cancer is Just the Beginning

When Cancer is Just the Beginning Mary Slattery at her home in New Jersey. Dustin Fenstermacher / wonderful machine Rarely, the body reacts to cancer by generating immune cells that chew their way into the brain. Could research with this handful of patients create a new therapeutic cancer vaccine? By Julia C. Mead • Photography by Dustin Fenstermacher Article Extras 1 But the antibody in Slattery's spinal fluid signified something more sinister: An immune re

Written byJulia C. Mead
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00

By Julia C. Mead • Photography by Dustin Fenstermacher

1 But the antibody in Slattery's spinal fluid signified something more sinister: An immune response to her cancer, theoretically arrested more than a year earlier, was so ferocious that it had chewed through the blood-brain barrier and into her cerebellum. Specifically, it had gnawed on Purkinje neurons that, like ovarian tumor cells, also express cdr2. Slattery had paraneoplastic cerebellar degeneration.

PCD is one of about a dozen paraneoplastic neurologic disorders (PNDs).2 Some, including PCD, are defined by an immune response to a malignancy that remains at a distance from the brain. PCD, associated with ovarian, breast, and small-cell lung cancer, is rare; accepted estimates put it at 1 in 10,000 cancer patients.

Significant improvement in its neurological condition is also rare. More often than not, the level of disability hits a plateau within just a few weeks. The menu of symptoms ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays